<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-F50NTTIPG</udiDi>
    <basicUdiDi>B-F50NTTIPG</basicUdiDi>
    <tradeName>NAVIBLEF TTO INTENSIVE CARE</tradeName>
    <deviceName>NAVIBLEF TTO INTENSIVE CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50NTTI</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:20.830Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-F50NTTDP6</udiDi>
    <basicUdiDi>B-F50NTTDP6</basicUdiDi>
    <tradeName>VIZULIZE - Blepharitis Eyelid foam</tradeName>
    <deviceName>NAVIBLEF TTO DAILY CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50NTTD</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:20.018Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-F50NTI6C</udiDi>
    <basicUdiDi>B-F50NTI6C</basicUdiDi>
    <tradeName>LIDBLEF INTENSIVE CARE</tradeName>
    <deviceName>NAVIBLEF TERP INTENSIVE CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50NTI</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:15.209Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-F50NTEDMR</udiDi>
    <basicUdiDi>B-F50NTEDMR</basicUdiDi>
    <tradeName>NAVIBLEF TERP DAILY CARE</tradeName>
    <deviceName>NAVIBLEF TERP DAILY CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50NTED</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:14.411Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-F50NIRX</udiDi>
    <basicUdiDi>B-F50NIRX</basicUdiDi>
    <tradeName>D-F50NIRX</tradeName>
    <deviceName>NAVIBLEF INTENSIVE CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50NI</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:13.610Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-F50NDRM</udiDi>
    <basicUdiDi>B-F50NDRM</basicUdiDi>
    <tradeName>NAVIBLEF  DAILY CARE</tradeName>
    <deviceName>NAVIBLEF DAILY CARE</deviceName>
    <manufacturerName>Novax Pharma SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000011256</manufacturerSrn>
    <authorisedRepresentativeName>International Associates Auditing &amp; Certification Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000002248</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F50ND</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:15:12.815Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-CNMF000016915YKAB6X</udiDi>
    <basicUdiDi>B-CNMF000016915YKAB6X</basicUdiDi>
    <tradeName>D-CNMF000016915YKAB6X</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shenzhen CERTAINN Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000016915</manufacturerSrn>
    <authorisedRepresentativeName>Shanghai International Holding Corp. GmbH(Europe)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000001</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>524CP0005/557CP0002</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-13T02:13:31.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-CNMF000016915YKAA6V</udiDi>
    <basicUdiDi>B-CNMF000016915YKAA6V</basicUdiDi>
    <tradeName>D-CNMF000016915YKAA6V</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shenzhen CERTAINN Technology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000016915</manufacturerSrn>
    <authorisedRepresentativeName>Shanghai International Holding Corp. GmbH(Europe)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000001</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>507CP0002/507CP1001/508CP0003/510CP0001</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T02:13:30.632Z</lastUpdated>
  </row>
  <row>
    <udiDi>B836TPSG2</udiDi>
    <basicUdiDi>B-B836TPSG2</basicUdiDi>
    <tradeName>RoboTip G2</tradeName>
    <deviceName>RoboTipG2</deviceName>
    <manufacturerName>Surgilum, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000018440</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TPSG2</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-12T20:54:24.236Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOMILLRINFRESCANTE9N</udiDi>
    <basicUdiDi>B-AFOMILLRINFRESCANTE9N</basicUdiDi>
    <tradeName>AFOMILL REVIGORANT</tradeName>
    <deviceName>AFOMILL RINFRESCANTE LENITIVO</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>519</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:25.369Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOMILLANTIARR9R</udiDi>
    <basicUdiDi>B-AFOMILLANTIARR9R</basicUdiDi>
    <tradeName>Afomill Decongestionant</tradeName>
    <deviceName>AFOMILL ANTIARROSSAMENTO</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>520</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:21.375Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOMILL38</udiDi>
    <basicUdiDi>B-AFOMILL38</basicUdiDi>
    <tradeName>AFOMILL</tradeName>
    <deviceName>AFOMILL RINFRESCANTE LENITIVO monodose</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>516</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:20.570Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOLENPLURIUT</udiDi>
    <basicUdiDi>B-AFOLENPLURIUT</basicUdiDi>
    <tradeName>AFOMILL</tradeName>
    <deviceName>AFOMILL RINRESCANTE LENITIVO 10 ml</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>515</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:19.769Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOANTIARRPLURI5C</udiDi>
    <basicUdiDi>B-AFOANTIARRPLURI5C</basicUdiDi>
    <tradeName>AFOMILL</tradeName>
    <deviceName>AFOMILL ANTIARROSSAMENTO 10 ml</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>517</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:18.965Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-AFOANTIARRMONOA3</udiDi>
    <basicUdiDi>B-AFOANTIARRMONOA3</basicUdiDi>
    <tradeName>AFOMILL</tradeName>
    <deviceName>AFOMILL ANTIARROSSAMENTO MONODOSE</deviceName>
    <manufacturerName>MONTEFARMACO OTC SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000013309</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>518</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-12T18:33:14.969Z</lastUpdated>
  </row>
  <row>
    <udiDi>06224009677139</udiDi>
    <basicUdiDi>803395976DT01DT003ZD</basicUdiDi>
    <tradeName>TWIT-TEAR XP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>C.O.C. FARMACEUTICI S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000019321</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>DT/01/DT/003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-11T16:07:34.107Z</lastUpdated>
  </row>
  <row>
    <udiDi>06224009677146</udiDi>
    <basicUdiDi>803395976DT01DT007ZM</basicUdiDi>
    <tradeName>TWIT-TEAR ALLERGY</tradeName>
    <deviceName></deviceName>
    <manufacturerName>C.O.C. FARMACEUTICI S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000019321</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>DT/01/DT/007</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-11T16:07:34.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-310053LW</udiDi>
    <basicUdiDi>B-310053LW</basicUdiDi>
    <tradeName>Hyaluron-ratiopharm Gel Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Optima Medical Swiss AG</manufacturerName>
    <manufacturerSrn>CH-MF-000041543</manufacturerSrn>
    <authorisedRepresentativeName>Optima Sanità S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000028430</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>310053</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:17:08.623Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-310052LU</udiDi>
    <basicUdiDi>B-310052LU</basicUdiDi>
    <tradeName>Hyaluron-ratiopharm Gel Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Optima Medical Swiss AG</manufacturerName>
    <manufacturerSrn>CH-MF-000041543</manufacturerSrn>
    <authorisedRepresentativeName>Optima Sanità S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000028430</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>310052</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:17:07.831Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-310051LS</udiDi>
    <basicUdiDi>B-310051LS</basicUdiDi>
    <tradeName>Hyaluron-ratiopharm Augentropfen</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Optima Medical Swiss AG</manufacturerName>
    <manufacturerSrn>CH-MF-000041543</manufacturerSrn>
    <authorisedRepresentativeName>Optima Sanità S.r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000028430</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>310051</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:17:07.030Z</lastUpdated>
  </row>
</eudamedExport>